| Released | Contributor | Author | Title | Pages | Price |
| 24-Nov-2009 | ValuEngine, Inc. |
N/A
| ValuEngine Industry Report for BIOTECHNOLOGY | 18 |
$49 |
| 23-Nov-2009 | Reuters Investment Profile |
N/A
| Hemispherx Biopharma, Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. | 12 |
$20 |
| 23-Nov-2009 | Plunkett Research, Ltd. | Jack W. Plunkett | Biotechnology & Genetics Industry Market Research and Competitive Analysis 2010 | 569 |
$299 |
| 23-Nov-2009 | Plunkett Research, Ltd. | Jack W. Plunkett | Biotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary) | 71 |
$199 |
| 23-Nov-2009 | ValuEngine, Inc. |
N/A
| ValuEngine Detailed Valuation Report for HEB | 13 |
$25 |
| 21-Nov-2009 | TheStreet.com Ratings |
N/A
| TheStreet.com Ratings Stock Report For: HEMISPHERX BIOPHARMA INC | 5 |
$25 |
| 21-Nov-2009 | Standard & Poor's Quantitative Report |
N/A
| Hemispherx BioPharma | 4 |
$25 |
| 20-Nov-2009 | Pechala's Reports | Frantisek Pechala | HEMISPHERX BIOPHARMA INC (HEB=US) 12-months forecast | 1 |
$15 |
| 20-Nov-2009 | Pechala's Reports | Lubomir Pechala | HEMISPHERX BIOPHARMA INC (HEB=US) 2-weeks forecast | 1 |
$10 |
| 19-Nov-2009 | Ford Investor Services, Inc. |
N/A
| Value Graph: HEMISPHERX BIO -- HEB | 1 |
$4 |
0.29% Nasdaq 
Research Reports
